NO20081230L - Inhibitorer av enzymet HIV integrase - Google Patents

Inhibitorer av enzymet HIV integrase

Info

Publication number
NO20081230L
NO20081230L NO20081230A NO20081230A NO20081230L NO 20081230 L NO20081230 L NO 20081230L NO 20081230 A NO20081230 A NO 20081230A NO 20081230 A NO20081230 A NO 20081230A NO 20081230 L NO20081230 L NO 20081230L
Authority
NO
Norway
Prior art keywords
inhibitors
hiv integrase
enzyme hiv
enzyme
integrase
Prior art date
Application number
NO20081230A
Other languages
English (en)
Norwegian (no)
Inventor
Klaus Ruprecht Dress
Ted William Johnson
Michael Bruno Plewe
Steven Paul Tanis
Huichun Zhu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081230(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20081230L publication Critical patent/NO20081230L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20081230A 2005-10-07 2008-03-07 Inhibitorer av enzymet HIV integrase NO20081230L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US72448405P 2005-10-07 2005-10-07
US73070105P 2005-10-26 2005-10-26
US76160506P 2006-01-24 2006-01-24
US82395406P 2006-08-30 2006-08-30
US82637906P 2006-09-20 2006-09-20
PCT/IB2006/002735 WO2007042883A1 (en) 2005-10-07 2006-09-25 Inhibitors of the hiv integrase enzyme

Publications (1)

Publication Number Publication Date
NO20081230L true NO20081230L (no) 2008-04-08

Family

ID=37684843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081230A NO20081230L (no) 2005-10-07 2008-03-07 Inhibitorer av enzymet HIV integrase

Country Status (21)

Country Link
US (1) US20070099915A1 (sr)
EP (1) EP1934220A1 (sr)
JP (1) JP2009511463A (sr)
KR (1) KR20080042171A (sr)
AP (1) AP2008004400A0 (sr)
AR (1) AR061398A1 (sr)
AU (1) AU2006300926A1 (sr)
BR (1) BRPI0616657A2 (sr)
CA (1) CA2623506A1 (sr)
CR (1) CR9859A (sr)
EA (1) EA200800758A1 (sr)
IL (1) IL189939A0 (sr)
MA (1) MA29855B1 (sr)
NL (1) NL2000255A1 (sr)
NO (1) NO20081230L (sr)
PE (1) PE20070494A1 (sr)
RS (1) RS20080141A (sr)
SV (1) SV2009002864A (sr)
TW (1) TW200800219A (sr)
UY (1) UY29843A1 (sr)
WO (1) WO2007042883A1 (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005103051A1 (en) * 2004-04-26 2005-11-03 Pfizer Inc. Inhibitors of the hiv integrase enzyme
CA2708281A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN102532021B (zh) * 2012-01-31 2013-10-16 天津大学 2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
AU2409992A (en) * 1991-08-08 1993-03-02 Tsumura & Co. Carcinostatic compound and production thereof
WO1995003311A1 (en) * 1993-07-19 1995-02-02 Xuande Luo Qinghaosu derivatives against aids
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
WO2001027309A1 (en) * 1999-10-13 2001-04-19 Merck & Co., Inc. Hiv integrase inhibitors
JP2004517802A (ja) * 2000-06-16 2004-06-17 ブリストルーマイヤーズ スクイブ カンパニー Ｈｉｖインテグラーゼ阻害剤
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
BRPI0407052A (pt) * 2003-01-27 2006-01-17 Pfizer Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização
WO2005103051A1 (en) * 2004-04-26 2005-11-03 Pfizer Inc. Inhibitors of the hiv integrase enzyme
JP2008512442A (ja) * 2004-09-07 2008-04-24 ファイザー・インク Ｈｉｖインテグラーゼ酵素の阻害剤

Also Published As

Publication number Publication date
BRPI0616657A2 (pt) 2011-06-28
SV2009002864A (es) 2009-02-19
CA2623506A1 (en) 2007-04-19
RS20080141A (sr) 2009-07-15
TW200800219A (en) 2008-01-01
IL189939A0 (en) 2008-08-07
JP2009511463A (ja) 2009-03-19
CR9859A (es) 2008-06-20
US20070099915A1 (en) 2007-05-03
KR20080042171A (ko) 2008-05-14
PE20070494A1 (es) 2007-06-13
EA200800758A1 (ru) 2008-08-29
EP1934220A1 (en) 2008-06-25
AP2008004400A0 (en) 2008-04-30
AR061398A1 (es) 2008-08-27
NL2000255A1 (nl) 2007-04-11
WO2007042883A1 (en) 2007-04-19
AU2006300926A1 (en) 2007-04-19
MA29855B1 (fr) 2008-10-03
UY29843A1 (es) 2007-05-31

Similar Documents

Publication Publication Date Title
WO2005115398A3 (en) Hiv integrase inhibitors
NO20081844L (no) Terapeutiske forbindelser
NO20063925L (no) Indazolderivater som inhibitorer av hormonsensitiv lipase
BRPI0510319A (pt) inibidores da enzima integrase de hiv
NO20055135L (no) Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
WO2009146555A8 (en) Hiv integrase inhibitors from pyridoxine
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
NO20044534L (no) Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer
NO20066055L (no) Pyridinderivater
NO20091299L (no) Substituerte sulfonamidderivater
NO20063958L (no) HIV integrase inhibitorer
NO20073404L (no) Kaliumsalt av en HIV-integraseinhibitor
NO20075992L (no) Forbindelser som modulerer C-Kit og C-FMS aktivitet og anvendelser derav
MX2010005334A (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana.
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
NO20081042L (no) PPAR aktive forbindelser
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20084049L (no) Forbindelser med forsterket ampa receptor og anvendelse derav i medisin
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
WO2007013047A3 (en) Water-dispersible anti-retroviral pharmaceutical compositions
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
NO20082130L (no) 3-Amino-1-arylpropylindoler og aza-substituerte indoler
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application